Pacira BioSciences Inc.

Pacira BioSciences Inc. is a pharmaceutical company focused on delivering non-opioid pain management solutions. Its flagship product, EXPAREL, is a long-acting, local analgesic that releases bupivacaine to manage postoperative pain while reducing reliance on opioids. Pacira targets various sectors within healthcare, including hospitals, surgical centers, and pain management clinics, driving a paradigm shift towards minimizing opioid usage in surgical recovery and chronic pain settings. The company's innovation extends to iovera°, a cryoanalgesia treatment utilizing extreme cold to block nerves and reduce pain temporarily, further diversifying its pain management portfolio. Based in Parsippany, New Jersey, Pacira BioSciences plays a crucial role in addressing the opioid epidemic by providing alternative pain management solutions, which align with broader public health initiatives seeking to improve patient outcomes and enhance post-surgical recovery protocols. Their contributions are significant in reducing opioid-related side effects and addiction risks, promoting the adoption of safer analgesic methods across medical practices.